Bioprognos Obtains the CE Marking for Its Algorithm to Support the Diagnostic of Lung Cancer
Bioprognos obtains the CE Declaration of Conformity for its algorithm to support the diagnostic of lung cancer after complying with the requirements of the European directive on medical devices and implementing a quality management system according to the standard UNE-EN ISO 13485:2016. - December 19, 2016
Press Releases 1 - 1 of 1